Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis;L'apolipoproteine E et ses alleles chez le sujet sain et au cours de l'atherosclerose

Annales de Biologie Clinique

Volumn 56, Issue 6, 1998, Pages 651-659

  Couderc, R ^a   Bailleul, S ^a  

^a HÔPITAL TENON   (France)

Author keywords

Apolipoprotein E; Atherosclerosis; Coronary heart disease; Myocardial infarction

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CHOLESTEROL; CHYLOMICRON; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; LIGAND;

ALLELE; ATHEROSCLEROSIS; EUROPE; GENE FREQUENCY; GEOGRAPHIC DISTRIBUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTRIGLYCERIDEMIA; REVIEW; ANIMAL; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASE; GENETICS; LIVER; METABOLISM; RISK FACTOR;

ALLELES; ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; GENE FREQUENCY; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; LIGANDS; LIVER; RISK FACTORS;

EID: 0031797958     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Kervinen K, Sodervik H, Makela J, et al. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype ? Gastroenterology 1996 ; 110 : 1785-90.
2. Siest G, Pillot T, Regis-Bailly A, et al. Apolipoprotein E : an important gene and protein to follow in laboratory medicine. Clin Chem 1995 ; 41 : 1068-86.
3. Bailleul S, Couderc R, Landais V, Lefevre G, Raichvarg D, Etienne J. Direct phenotyping of human apolipoprotein E in plasma : application to population frequency distribution in Paris (France). Hum Hered 1993 ; 43 : 159-65.
4. Brouwer DA, Van Doormaal JJ, Muskiet FA. Clinical chemistry of common apolipoprotein E isoforms. J Chromatogr B BioMed Appl 1996 ; 678 : 23-41.
5. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990 ; 31 : 545-8.
6. Corbo RM, Scacchi R, Mureddu L, Mulas G, Alfano G. Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique. Comparison with frequency data of other European populations. Ann Hum Genet 1995 ; 59 : 197-209.
7. Cumming AM, Robertson FW. Polymorphism at the apoprotein E locus in relation to risk of coronary disease. Clin Genet 1984 ; 25 : 310-3.
8. Lenzen HJ, Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 1986 ; 32 : 778-81.
9. Eto M, Watanabe K, Makino I. Increased frequencies of apolipoprotein epsilon 2 and epsilon 4 alleles in patients with ischemic heart disease. Clin Genet 1989 ; 36 : 183-8.
10. Yamamura T, Tajima S, Miyake Y, Nomura S, Yamamoto A, Haze K, Hiramori K. Hyperlipoproteinemia as a risk factor for ischemic heart disease. Jpn Circ J 1990 ; 54 : 448-56.
11. Eichner JE, Kuller LH, Orchard TJ, et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993 ; 71 : 160-5.
12. Luc G, Bard JM, Arveiler D, et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The Ectim study. Arterioscler Thromb 1994 ; 14 : 1412-9.
13. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994 ; 272 : 1666-71.
14. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995 ; 91 : 265-9.
15. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease : A meta-analysis. Arterioscler Thromb Vasc Biol 1996 ; 16 : 1250-5.
16. Utermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 1984 ; 65 : 237-41.
17. Moore JH, Reilly SL, Ferrell RE, Sing CF. The role of the apoliprotein E polymorphism in the prediction of coronary artery diseuse age of onset. Clin Genet 1997 ; 51 : 22-5.
18. Dong L, Wilson C, Wardell MR, et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 1994 ; 269 : 22358-65.
19. Luc G, Ducimetiere P, Bard JM, et al. Distribution of apolipoprotein E between apo B-and non apo B-containing lipoproteins according to apo E phenotype. Atherosclerosis 1997 ; 131 : 257-62.
20. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988 ; 8 : 1-21.
21. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism : A comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991 ; 49 : 338-49.
22. Gylling H, Kontula K, Koivisito UM, Miettinen HE, Miettinen TA. Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact. Arterioscler Thromb Vasc Biol 1997 ; 17 : 38-44.
23. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype : a meta-analysis. J Lipid Res 1992 ; 33 : 447-54.
24. Salah D, Bohnet K, Gueguen R, Siest G, Visvikis S. Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort. J Lipid Res 1997 ; 38 : 904-12.
25. St-Amand J, Moorjanit S, Lupien PJ, Prud'homme D, Despres JP. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotein E polymorphism. Metabolism 1996 ; 45 : 261-7.
26. Miettinen TA, Gylling H, Vanhanen H. Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet 1988 ; 2 : 1261.
27. Tikkanen MJ, Huttunen JK, Ehnholm C, Pietinen P. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990 ; 10 : 285-8.
28. Nestruck AC, Bouthillier D, Sing CF, Davignon J. Apolipoprotein E polymorphism and plasma cholesterol response to probucol. Metabolism 1987 ; 36 : 743-7.
29. Nestel P, Simons L, Barter P, et al. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia : prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin. Atherosclerosis 1997 ; 129 : 231-9.
30. Carmena R, Roederer G, Mailloux H, Lussier-Cacan S, Davignon J. The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism 1993 ; 42 : 895-901.
31. O'Malley JP, Illingworth DR. The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia. Metabolism 1990 ; 39 : 150-4.
32. Kayden HJ, Maschio F, Traber MG. The secretion of apolipoprotein E by human monocyte-derived macrophages. Arch Biochem Biophys 1985 ; 239 : 388-95.
33. Plump AS, Breslow JL. Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu Rev Nutr 1995 ; 15 : 495-518.
34. Paszty C, Maeda N, Verstuyft J, Rubin EM. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest 1994 ; 94 : 899-903.
35. Mazzone T. Apolipoprotein E secretion by macrophages : its potential physiological functions. Curr Opin Lipidol 1996 ; 7 : 303-7.